Citrus lemon peel extract versus metformin in testosterone-induced polycystic ovary syndrome: An experimental study
Abstract
Background: Metformin is the standard therapy for metabolic disturbances in polycystic ovary syndrome (PCOS), but its gastrointestinal side effects prompt the search for alternatives. Lemon peel extract (LPE) possesses anti-inflammatory and anti-diabetic properties that may support PCOS management.
Objective: To evaluate the effects of LPE, metformin, and their combination on tumor necrosis factor-α (TNF-α), homeostatic model assessment of insulin resistance (HOMA-IR), and fasting blood glucose (FBG) in testosterone-induced PCOS rats.
Materials and methods: An experimental study was conducted on 32 females Rattus norvegicus (12 wk, 130-170 gr), divided into 4 groups (n = 8): untreated PCOS, PCOS + LPE at dose 500 mg/kg, PCOS + metformin at dose 200 mg/kg, and PCOS with combination LPE 500 mg/kg + metformin 200 mg/kg. PCOS was induced with testosterone propionate (10 mg/kg) for 21 days, followed by 14 days of treatment. 24 hr after the last treatment, blood samples were collected to measure TNF-α, insulin and FBG using the enzyme-linked immunoassay method. HOMA-IR was calculated from insulin and FBG levels.
Results: LPE significantly reduced TNF-α, HOMA-IR, and FBG compared with the untreated PCOS rats (p < 0.001), no significant differences were observed when compared with metformin administration (TNF-α, p = 0.945; HOMA-IR, p = 0.554; FBG, p = 0.575). Additionally, combination therapy of LPE and metformin resulted in a greater reduction in HOMA-IR and FBG than single…
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.